Clinical Colorectal Cancer
Latest Publications

TOTAL DOCUMENTS

1398

(FIVE YEARS 294)

H-INDEX

(FIVE YEARS 9)

Published By Elsevier

1938-0674, 1533-0028

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Tumor-infiltrating PD-1+ immune cell density is associated with response to neoadjuvant chemoradiotherapy in rectal cancer

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2022.01.004 ◽

2022 ◽

Author(s):

Yusuke Kitagawa ◽

Takashi Akiyoshi ◽

Noriko Yamamoto ◽

Toshiki Mukai ◽

Yukiharu Hiyoshi ◽

...

Keyword(s):

Rectal Cancer ◽

Cell Density ◽

Immune Cell ◽

Neoadjuvant Chemoradiotherapy

Download Full-text

Restoring immune mediated disease control by ipilimumab re-exposition in a heavily pre-treated patient with MSI-H mCRC

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2022.01.003 ◽

2022 ◽

Author(s):

Frank Jordan ◽

Martin Trepel ◽

Rainer Claus

Keyword(s):

Disease Control ◽

Treated Patient ◽

Immune Mediated

Download Full-text

Intraoperative radiation after pelvic short course radiation-based total neoadjuvant therapy for patients with rectal adenocarcinoma at high risk for local recurrence.

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2022.01.002 ◽

2022 ◽

Author(s):

Zooha Khan ◽

Michael K. Rooney ◽

Prajnan Das ◽

Ethan B. Ludmir ◽

Eugene J. Koay ◽

...

Keyword(s):

High Risk ◽

Local Recurrence ◽

Neoadjuvant Therapy ◽

Rectal Adenocarcinoma ◽

Intraoperative Radiation ◽

Short Course ◽

Total Neoadjuvant Therapy

Download Full-text

Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survival

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2022.01.005 ◽

2022 ◽

Author(s):

Davide Ciardiello ◽

Vincenzo Famiglietti ◽

Stefania Napolitano ◽

Lucia Esposito ◽

Filippo Pietrantonio ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Neutrophil To Lymphocyte Ratio ◽

Wild Type ◽

Lymphocyte Ratio ◽

Colorectal Cancer Patients

Download Full-text

Rechallenge with BRAF and anti-EGFR inhibitors in patients with metastatic colorectal cancer harboring BRAF mutation who progressed on cetuximab and encorafenib with or without binimetinib: a case series

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2021.12.001 ◽

2021 ◽

Author(s):

Ji Jingran ◽

Wang Chongkai ◽

Fakih Marwan

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Braf Mutation ◽

Case Series ◽

Egfr Inhibitors

Download Full-text

Impact of Tumor Location on Patient Outcomes in Small Bowel Cancers

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2021.11.006 ◽

2021 ◽

Author(s):

Irene S. Yu ◽

Zamzam Al-Hashami ◽

Parv Chapani ◽

Caroline Speers ◽

Janine M. Davies ◽

...

Keyword(s):

Small Bowel ◽

Patient Outcomes ◽

Tumor Location

Download Full-text

Editorial Board

Clinical Colorectal Cancer ◽

10.1016/s1533-0028(21)00115-8 ◽

2021 ◽

Vol 20 (4) ◽

pp. A1

Download Full-text

TRIFLURIDINE/TIPIRACIL IN COMBINATION WITH BEVACIZUMAB IN FIRST-LINE FOR METASTATIC COLORECTAL CANCER: A WAY FORWARD. A POINT OF VIEW BASED ON COST-EFFECTIVENESS

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2021.11.012 ◽

2021 ◽

Author(s):

Jacopo Giuliani

Keyword(s):

Colorectal Cancer ◽

Cost Effectiveness ◽

Metastatic Colorectal Cancer ◽

Point Of View ◽

First Line

Download Full-text

Clinical Colorectal Cancer ◽

10.1016/s1533-0028(21)00116-x ◽

2021 ◽

Vol 20 (4) ◽

pp. A3-A6

Download Full-text

Modification to systemic anticancer therapy at the start of the COVID-19 pandemic and its overall impact on survival outcomes in patients with colorectal cancer

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2021.11.010 ◽

2021 ◽

Author(s):

Konstantinos Kamposioras ◽

Kok Haw Jonathan Lim ◽

Joseph Williams ◽

Mohammed Alani ◽

Jorge Barriuso ◽

...

Keyword(s):

Colorectal Cancer ◽

Anticancer Therapy ◽

Survival Outcomes ◽

Impact On Survival

Download Full-text

Clinical Colorectal Cancer
Latest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Elsevier

Tumor-infiltrating PD-1+ immune cell density is associated with response to neoadjuvant chemoradiotherapy in rectal cancer

Restoring immune mediated disease control by ipilimumab re-exposition in a heavily pre-treated patient with MSI-H mCRC

Intraoperative radiation after pelvic short course radiation-based total neoadjuvant therapy for patients with rectal adenocarcinoma at high risk for local recurrence.

Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survival

Rechallenge with BRAF and anti-EGFR inhibitors in patients with metastatic colorectal cancer harboring BRAF mutation who progressed on cetuximab and encorafenib with or without binimetinib: a case series

Impact of Tumor Location on Patient Outcomes in Small Bowel Cancers

Editorial Board

TRIFLURIDINE/TIPIRACIL IN COMBINATION WITH BEVACIZUMAB IN FIRST-LINE FOR METASTATIC COLORECTAL CANCER: A WAY FORWARD. A POINT OF VIEW BASED ON COST-EFFECTIVENESS

Table of contents

Modification to systemic anticancer therapy at the start of the COVID-19 pandemic and its overall impact on survival outcomes in patients with colorectal cancer

Export Citation Format

Clinical Colorectal CancerLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Elsevier

Tumor-infiltrating PD-1+ immune cell density is associated with response to neoadjuvant chemoradiotherapy in rectal cancer

Restoring immune mediated disease control by ipilimumab re-exposition in a heavily pre-treated patient with MSI-H mCRC

Intraoperative radiation after pelvic short course radiation-based total neoadjuvant therapy for patients with rectal adenocarcinoma at high risk for local recurrence.

Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survival

Rechallenge with BRAF and anti-EGFR inhibitors in patients with metastatic colorectal cancer harboring BRAF mutation who progressed on cetuximab and encorafenib with or without binimetinib: a case series

Impact of Tumor Location on Patient Outcomes in Small Bowel Cancers

Editorial Board

TRIFLURIDINE/TIPIRACIL IN COMBINATION WITH BEVACIZUMAB IN FIRST-LINE FOR METASTATIC COLORECTAL CANCER: A WAY FORWARD. A POINT OF VIEW BASED ON COST-EFFECTIVENESS

Table of contents

Modification to systemic anticancer therapy at the start of the COVID-19 pandemic and its overall impact on survival outcomes in patients with colorectal cancer

Clinical Colorectal Cancer
Latest Publications